Abstract Submission

Important Dates

Steps for Abstract Submission

• Step 1 Read the abstract guideline and the following information
• Step 2 Click on “Abstract Submission”, and Sign up or Log in
• Step 3 Complete and submit all required information
• Step 4 Receive confirmation of the submission

Topic Categories

• -Submitted abstracts will be reviewed by the Scientific Committee according to the topics.

Acute myeloid leukemia	-Diagnosis and prognostication -Treatment including induction treatment, stem cell transplantation and salvage treatment -Clinical trials including novel drugs
Acute lymphoblastic leukemia	-Diagnosis and prognostication -Treatment including induction treatment, stem cell transplantation and salvage treatment -Clinical trials including novel drugs
Bone marrow failure	-Aplastic anemia -Myelodysplastic syndrome -Other disorders
Cellular therapy	-In vitro and pre-clinical study -Clinical trials with cell therapy
Blood and marrow collection and processing	-Hematopoietic stem cell collection -Mobilization and processing -Growth factors and cytokines
Infectious complications	-Acute infectious complications related with stem cell transplantation -Late infectious complications from transplant survivors -Vaccination and prevention of infection
Lymphoma	-Genomics of lymphoma -Induction and salvage treatment for lymphoma -Autologous and allogeneic stem cell transplantation for lymphoma -Post-transplantation failure management
Post-transplant complications (Non-infectious)	-Acute and chronic GVHD -Other acute complications -Late complications -Long-term survivor management
Myeloma	-Genomics of myeloma -Induction and salvage treatment for myeloma -Autologous and allogeneic stem cell transplantation for myeloma -Post-transplantation failure management
Nursing/Allied health	-Quality of life -Stem cell donation -Nursing care for stem cell transplantation -Nutritional support -Education of post-transplant survivors
Pediatric hematology/Oncology	-Pediatric hematologic malignancy -Pediatric nonmalignant disease -Pediatric oncology
Transplantation process and preparative regimens	-Conditioning regimens -Transplantation protocols -Cord blood transplantation -Haploidentical transplantation -Donor selection process
Stem cell biology	-Cancer stem cells -Hematopoietic stem cells
Others	-Others

Abstract Submission Guidelines

Theses guidelines are for general participants, not invited speakers.

• -All abstracts must be submitted online prior to July 11, 2021. Abstracts received after the deadline will not be considered.
• -Abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication.

Title	-Capitalize the first letter of each word -Not exceed 150 letters including spaces
Author Information	-Name: Write first and family name(s) in full. -Affiliation should be structured as follows: Department, Institution, Country -Degrees or titles such as MD after an author’s name must be deleted.
Abstract Body	-Divide into four sections: Background, Methods, Results, Conclusions -Not exceed 600 words
Keywords	No more than 6 keywords with each word capitalized.

• -No additional proofreading or corrections will be allowed after the submission deadline. It is the responsibility of the authors to ensure that their text does not contain typos or grammatical errors.
• -Authors have the option of choosing their presentation type. However, the scientific program committee will make the final decision after review.
• -The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission to the Secretariat.
• -ICBMT 2021 will publish all accepted abstracts online (open access) for a period of at least 5 years. The abstract published online will include the e-mail address of the presenting author. As a condition of submission, ICBMT 2021 requires you to agree to such publication and to surrender any copyright over the abstract as submitted to ICBMT 2021.
• -Abstracts must be original and must not be or have been published or presented at any other meeting prior to The International Congress of BMT 2021.
• -Presenting authors of abstracts must be registered participants.
• -Registration must be received by the Secretariat by the Registration Deadline to ensure inclusion of the abstract in the meeting publications and in order to be scheduled for presentation.

Notification of Acceptance

• -The acceptance notice will be e-mailed to the presenter by July 23, 2021
• -All submitted abstracts will be reviewed by the Scientific Program Committee according to reviewing procedures.

Abstract Withdrawal

• -If the presenting author of an accepted abstract does not register by August 3, 2021, the abstract will be automatically withdrawn from the final program.
• -If you have to withdraw an abstract, please notify the secretariat (icbmt@icbmt.or.kr) in writing as soon as possible.